Pharmacokinetic Study on N-acetylneuraminic Acid

计划入组 6 人 · 首次发布于 2010 年 11 月 9 日

Sialic Acid Supplementation in N-Acetylneuraminic Acid Synthase (NANS) Deficiency

计划入组 10 人 · 首次发布于 2018 年 6 月 4 日

N-3 Fatty Acid Requirements for Human Development

计划入组 270 人 · 首次发布于 2008 年 2 月 21 日

Cytidine-5'-Monophosphate-5-N-Acetylneuraminic Acid

C₂₀H₃₁N₄O₁₆P

2-deoxy-2,3-dehydro-N-acetylneuraminic acid

C₁₁H₁₇NO₈

Zanamivir(Relenza, Dectova)

C₁₂H₂₀N₄O₇ · Rx

N&N Pharmaceuticals, Inc.

United States

Shanghai Ajinomoto Amino Acid Co., Ltd.

China

n-Lorem Foundation

United States

Global Metabolic Disruption Discovered in SMA Patients: N-acetylneuraminic Acid Shows Treatment Potential

FDA Clears Ultragenyx IND Application for UX016 to Treat Rare GNE Myopathy

Advancing Personalized Medicine: The Rise of N-of-1 Therapies for Rare Diseases